80 Publications (Page 3 of 4)
2011
Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer
Aljuffali, Ibrahim AAljuffali, Ibrahim AMock, Jason NMock, Jason NCostyn, Leah JCostyn, Leah JNguyen, HaNguyen, HaNagy, TamasNagy, TamasCummings, Brian SCummings, Brian SArnold, Robert D and Arnold, Robert D
Cancer Biology & Therapy, vol. 12, (no. 5), pp. 420, 9/1/2011. | Journal Article
 
Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer.
Aljuffali, Ibrahim AAljuffali, Ibrahim AMock, Jason NMock, Jason NCostyn, Leah JCostyn, Leah JNguyen, HaNguyen, HaNagy, TamasNagy, TamasCummings, Brian SCummings, Brian SArnold, Robert D and Arnold, Robert D
Cancer biology & therapy, vol. 12, (no. 5), pp. 407-20, 2011/Sep/1. | Journal Article
 
Secretory phospholipase A2 responsive liposomes
Zhu, GuodongZhu, GuodongMock, Jason NMock, Jason NAljuffali, IbrahimAljuffali, Ibrahim ACummings, Brian SCummings, Brian SArnold, Robert D and Arnold, Robert D
Journal of Pharmaceutical Sciences, vol. 100, (no. 8), pp. 3159, August 2011. | Journal Article
 
Secretory phospholipase A₂ responsive liposomes.
Zhu, GuodongZhu, GuodongMock, Jason NMock, Jason NAljuffali, IbrahimAljuffali, Ibrahim ACummings, Brian SCummings, Brian SArnold, Robert D and Arnold, Robert D
Journal of pharmaceutical sciences, vol. 100, (no. 8), pp. 3146-59, 2011/Aug. | Journal Article
 
Synthesis of lipids for development of multifunctional lipid-based drug-carriers.
Zhu, GuodongZhu, GuodongAlhamhoom, YahyaAlhamhoom, YahyaCummings, Brian SCummings, Brian SArnold, Robert D and Arnold, Robert D
Bioorganic & medicinal chemistry letters, vol. 21, (no. 21), pp. 6370-5, 2011/Nov/1. | Journal Article
 
The antioxidant phenylaminoethyl selenide reduces doxorubicin-induced cardiotoxicity in a xenograft model of human prostate cancer.
Kang, Jeong YKang, Jeong YeonCostyn, Leah JCostyn, Leah JNagy, TamasNagy, TamasCowan, Elizabeth ACowan, Elizabeth AOldham, Charlie DOldham, Charlie DMay, Sheldon WMay, Sheldon WArnold, Robert D and Arnold, Robert D
Archives of biochemistry and biophysics, vol. 515, (no. 1-2), pp. 112-9, 2011/Nov. | Journal Article
2010
Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo.
Zhang, ShuzhongZhang, ShuzhongSagawa, KazukoSagawa, KazukoArnold, Robert DArnold, Robert DTseng, ElaineTseng, ElaineWang, XiaodongWang, XiaodongMorris, Marilyn E and Morris, Marilyn E
Journal of pharmaceutical sciences, vol. 99, (no. 1), pp. 430-41, 2010/Jan. | Journal Article
 
Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: In vitro and in vivo
Zhang, ShuzhongZhang, ShuzhongSagawa, KazukoSagawa, KazukoArnold, Robert DArnold, Robert DTseng, ElaineTseng, ElaineWang, XiaodongWang, XiaodongMorris, Marilyn E and Morris, Marilyn E
Journal of Pharmaceutical Sciences, vol. 99, (no. 1), pp. 441, January 2010. | Journal Article
2009
Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients
Bulitta, JürgenBulitta, JürgenBulitta, Jürgen BZhao, PingZhao, PingZhao, PingArnold, RobertArnold, RobertArnold, Robert DKessler, Dean RKessler, DeanKessler, DeanDaifuku, RichardDaifuku, RichardDaifuku, RichardPratt, JamesPratt, JamesPratt, JamesLuciano, GabrielLuciano, GabrielLuciano, GabrielHanauske, Axel-RHanauske, Axel-RHanauske, Axel-RGelderblom, HansGelderblom, HansGelderblom, HansAwada, AhmadAwada, AhmadAwada, AhmadJusko, WilliamJusko, William and Jusko, William
Cancer chemotherapy and pharmacology., vol. 63, (no. 6), pp. 1049-1063, 2009. | Journal Article
 
Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients
Bulitta, Juergen BZhao, PingArnold, Robert DKessler, Dean RDaifuku, RichardPratt, JamesLuciano, GabrielHanauske, Axel-RGelderblom, HansAwada, Ahmad and Jusko, William
Cancer Chemotherapy and Pharmacology, vol. 63, (no. 6), pp. 1035-1048, 2009. | Journal Article
2007
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer
O’Connor, R.O’Leary, M.Ballot, J.Collins, C.D.Kinsella, P.Mager, D.E.Arnold, R.D.O’Driscoll, L.Larkin, A.Kennedy, S.Fennelly, D.Clynes, M. and Crown, J.
Cancer Chemotherapy and Pharmacology, vol. 59, pp. 79-87. | Journal Article
 
Biotechnology-Derived Drug Product Development
Carl, S.M.Lindley, D.J.Knipp, G.T.Morris, K.R.Oliver, E.Becker, G.W. and Arnold, R.D.
2007
2006
A Phase 1 clinical and pharmacokinetic study of the Multidrug Resistance Protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer
O'Conner, RO'Leary, M.O., Ballot, R., Collins, C., Kinsella, P., Mager, D.M., Arnold, R.D., O'Driscoll, L.O., Larkin, A.M., Kennedy, S., Fennelly, D., Clynes, M., and Crown, J. and Arnold, Robert D
Cancer Chemotherapy and Pharmacology, 2006. | Journal Article
2005
Effect of repetitive administration of doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution
Arnold, Robert DMager, D.E.Slack, J.E. and Straubinger, R.M
Clinical Cancer Research, 2005. | Journal Article
 
Effect of Repetitive Administration of Doxorubicin-Containing Liposomes on Plasma Pharmacokinetics and Drug Biodistribution in a Rat Brain Tumor Model
Arnold, RobertArnold, Robert DMager, Donald EMager, DonaldSlack, Jeanine ESlack, JeanineStraubinger, Robert and Straubinger, Robert M
Clinical Cancer Research, vol. 11, (no. 24), pp. 8865, 20051215. | Journal Article
 
Effect of Repetitive Administration of Doxorubicin-Containing Liposomes on Plasma Pharmacokinetics and Drug Biodistribution in a Rat Brain Tumor Model
Arnold, RobertArnold, Robert DMager, Donald EMager, DonaldSlack, Jeanine ESlack, JeanineStraubinger, Robert and Straubinger, Robert M
Clinical Cancer Research, vol. 11, (no. 24), pp. 8856-8865, 2005. | Journal Article
 
Tumor antivascular effects of sterically-stabilized doxorubicin-containing liposomes
Arnold, R.D.,Mager, D.E., Spernyak, J.A., Mazurchuk, R.V., Straubinger, R. and Arnold, Robert D
AACR National Meeting, Anaheim, CA.. 2005. | Conference Proceeding
2004
Altered plasma pharmacokinetics, tumor/tissue biodistribution, and barrier properties of the tumor microvasculature in rats following repetitive dosing of doxorubicin liposomes
Arnold, R.D.,Slack, J.E., Mager, D.E., R., Spernyak, J., Mazurchuk, R., Straubinger, R. and Arnold, Robert D
Advances in Liposomes: New Technologies and New Therapies, Chicago, IL. 2004. | Conference Proceeding
 
Antivascular and antitumor activities of liposome-associated drugs
Straubinger RMArnold, Robert DZhou RMazurchuk R and Slack JE
Anticancer Research, vol. 24, (no. 2A), pp. 397-404, Mar-Apr 2004. | Journal Article
 
Antivascular and antitumor activities of liposome-associated drugs.
Straubinger, Robert MArnold, Robert DZhou, RongMazurchuk, Richard and Slack, Jeanine E
Anticancer research, vol. 24, (no. 2A), pp. 397-404, 2004 Mar-Apr. | Journal Article
 
Antivascular and Antitumor Activities of Liposome-associated Drugs
Straubinger, Robert MArnold, Robert DZhou, R.Mazurchuk, R. and Slack, JE
Anticancer Research, vol. 24, (no. 2A), pp. 397-404, 2004. | Journal Article
 
Effect of repetitive administration of doxorubicin encapsulated in sterically stabilized liposomes on plasma kinetics, brain tumor/tissue drug deposition, and tumor vascular permeability in Rats
Arnold, R.D.,Slack, J.E., Mager, D.E., and Straubinger R.M. and Arnold, Robert D
AACR National Meeting, Orlando, FL. 2004. | Conference Proceeding
 
Increased brain tumor deposition of doxorubicin liposomes following repetitive dosing: alterations in plasma pharmacokinetics and barrier properties of the tumor microvasculature in rats
Arnold, R.D.,Slack, J.E., Mager, D.E., and Straubinger, R., and Arnold, Robert D
AAPS National Meeting, Baltimore, MD. 2004. | Conference Proceeding
 
Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.
Arnold, Robert DArnold, Robert DSlack, Jeanine ESlack, Jeanine EStraubinger, Robert M and Straubinger, Robert M
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, vol. 808, (no. 2), pp. 141-52, 2004/Sep/5. | Journal Article
 
Tumor antivascular effects of liposome-incorporated drugs (Dissertation)
Arnold, Robert D (2004).